BioCentury | Aug 29, 2020
Product Development
Next-wave Th1 cytokine cancer therapies aim for more precise targeting
...Biosciences Inc.
Obsidian Therapeutics Inc.
Repertoire Immune Medicines Inc.
GlaxoSmithKline plc
Simcha Therapeutics Holding Co. LLC
Xilio...